Patient Satisfaction in Stroke Patients (PatZuFrie)

This study has been completed.
Sponsor:
Collaborator:
German Federal Ministry of Education and Research
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00994409
First received: October 13, 2009
Last updated: November 30, 2010
Last verified: November 2010
  Purpose

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.


Condition
Stroke

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall

Resource links provided by NLM:


Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness. [ Time Frame: September 2010 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Compliance/adherence with discharge medication Activities of daily living [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
  • Re-events [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
  • Degree of Disability [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
  • Mortality [ Time Frame: September 2010 ] [ Designated as safety issue: No ]

Estimated Enrollment: 1200
Study Start Date: July 2008
Study Completion Date: November 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Stroke and TIA patients treated at the Charite with acute stroke or TIA onset less than 7 days

Criteria

Inclusion Criteria:

  • all patients eligible

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00994409

Locations
Germany
Dept. Neurology, Charité Campus Benjamin Franklin
Berlin, Germany
Sponsors and Collaborators
Charite University, Berlin, Germany
German Federal Ministry of Education and Research
Investigators
Principal Investigator: Peter U Heuschmann, Professor Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: Christian H Nolte MD, Dept. Neurology, Charite Campus Benjamin Franklin
ClinicalTrials.gov Identifier: NCT00994409     History of Changes
Other Study ID Numbers: CSB-PatZuFrie, EA4/019/08
Study First Received: October 13, 2009
Last Updated: November 30, 2010
Health Authority: Germany: Ethics Commission

Keywords provided by Charite University, Berlin, Germany:
Stroke

Additional relevant MeSH terms:
Stroke
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on April 16, 2014